
    
      The pilot trial in aim three will include enrolling four primary care practices. Each of the
      participating practices will be randomized to one of two arms and accordingly enrolled
      participants from each clinic will be assigned to one of two conditions:

      Condition 1. Receive lifestyle modification alone (Diabetes Prevention Program (DPP).

      Condition 2. Receive lifestyle modification (DPP) with metformin therapy recommendation.

      Twenty five participants will be enrolled from each participating practice. Participants will
      be followed up for 12-14 months after recruitment.
    
  